Dr. Rupal Shah, MD

NPI: 1396730560
Total Payments
$7,539
2024 Payments
$121.73
Companies
32
Transactions
236
Medicare Patients
1,356
Medicare Billing
$204,160

Payment Breakdown by Category

Food & Beverage$6,019 (79.8%)
Consulting$1,200 (15.9%)
Travel$293.16 (3.9%)
Education$26.37 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,019 232 79.8%
Consulting Fee $1,200 1 15.9%
Travel and Lodging $293.16 1 3.9%
Education $26.37 2 0.3%

Top Paying Companies

Company Total Records Latest Year
Biohaven Pharmaceutical Holding Company Ltd. $1,905 7 $0 (2022)
AstraZeneca Pharmaceuticals LP $1,885 95 $0 (2024)
Amgen Inc. $1,822 62 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $284.37 15 $0 (2024)
GlaxoSmithKline, LLC. $136.66 8 $0 (2020)
Janssen Pharmaceuticals, Inc $132.86 4 $0 (2020)
Medtronic Vascular, Inc. $124.20 1 $0 (2017)
Gilead Sciences, Inc. $120.00 1 $0 (2019)
AbbVie Inc. $112.68 5 $0 (2021)
Sunovion Pharmaceuticals Inc. $102.86 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $121.73 6 AstraZeneca Pharmaceuticals LP ($36.43)
2023 $482.89 24 AstraZeneca Pharmaceuticals LP ($208.11)
2022 $2,270 26 Biohaven Pharmaceutical Holding Company Ltd. ($1,905)
2021 $961.43 46 Amgen Inc. ($369.39)
2020 $804.37 41 AstraZeneca Pharmaceuticals LP ($321.50)
2019 $1,030 34 AstraZeneca Pharmaceuticals LP ($359.41)
2018 $778.33 28 Amgen Inc. ($344.22)
2017 $1,090 31 Amgen Inc. ($318.92)

All Payment Transactions

236 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
10/24/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $26.82 General
05/29/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $21.66 General
Category: Inflammation
05/09/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.95 General
Category: Cardiovascular and Metabolism
05/07/2024 Phadia US Inc. ImmunoCAP (Device) Food and Beverage Cash or cash equivalent $23.19 General
Category: Allergy/Immunology
04/18/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $13.63 General
Category: Inflammation
01/19/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $19.48 General
Category: Respiratory
11/28/2023 Phadia US Inc. ImmunoCAP (Device) Food and Beverage Cash or cash equivalent $23.59 General
Category: Allergy/Immunology
11/16/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $17.74 General
Category: Diabetes
11/14/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $12.39 General
Category: Inflammation
10/26/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $120.39 General
Category: Cardiology
09/21/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $4.15 General
Category: Inflammation
09/18/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $18.71 General
Category: Cardiovascular and Metabolism
09/05/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $18.95 General
Category: Cardiovascular and Metabolism
08/25/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.33 General
Category: Cardiovascular and Metabolism
07/20/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $6.20 General
Category: Inflammation
07/11/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.68 General
Category: Cardiovascular and Metabolism
06/29/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $12.73 General
Category: Cardiovascular and Metabolism
06/25/2023 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $20.26 General
Category: Diabetes Care
05/25/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $4.79 General
Category: Inflammation
04/03/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $9.29 General
Category: Inflammation
03/28/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.59 General
Category: Cardiovascular and Metabolism
03/06/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $42.11 General
Category: Cardiovascular and Metabolism
02/28/2023 Hologic Sales and Service, LLC APTIMA (Device), THINPREP 2000 PROCESSOR Food and Beverage In-kind items and services $18.73 General
Category: Diagnostics
02/28/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $4.59 General
Category: Inflammation
02/21/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $18.57 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 348 701 $252,991 $58,407
2022 8 262 508 $191,468 $45,633
2021 9 323 540 $194,298 $52,753
2020 10 423 655 $127,649 $47,368
Total Patients
1,356
Total Services
2,404
Medicare Billing
$204,160
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 83 344 $149,296 $31,725 21.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 53 53 $36,782 $7,064 19.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 55 113 $28,815 $6,848 23.8%
99496 Transitional care management services for problem of high complexity Office 2023 20 23 $12,811 $5,255 41.0%
99483 Assessment of and care planning for patient with impaired thought processing, typically 60 minutes Office 2023 27 27 $14,534 $4,894 33.7%
G0008 Administration of influenza virus vaccine Office 2023 34 34 $3,467 $1,083 31.2%
90686 Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage Office 2023 40 40 $3,040 $876.00 28.8%
99497 Advance care planning, first 30 minutes Office 2023 14 14 $2,338 $472.57 20.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 11 12 $348.00 $143.76 41.3%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 11 41 $1,560 $44.48 2.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 82 272 $117,871 $24,474 20.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 43 89 $23,567 $5,213 22.1%
99483 Assessment of and care planning for impaired thought processing, typically 50 minutes Office 2022 26 26 $14,534 $5,209 35.8%
99496 Transitional care management services for problem of high complexity Office 2022 15 22 $12,254 $4,918 40.1%
90662 Influenza vaccine split virus, preservative free Office 2022 32 32 $7,808 $2,193 28.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 12 12 $8,328 $1,628 19.6%
G0008 Administration of influenza virus vaccine Office 2022 33 33 $3,432 $1,022 29.8%
99497 Advance care planning, first 30 minutes Office 2022 19 22 $3,674 $976.72 26.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 78 225 $96,508 $21,105 21.9%
99483 Assessment of and care planning for patient with impaired thought processing, typically 50 minutes Office 2021 47 58 $32,422 $13,303 41.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 49 103 $23,919 $6,463 27.0%
99496 Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge Office 2021 12 14 $7,571 $3,202 42.3%
90662 Vaccine for influenza for injection into muscle, split virus, preservation free Office 2021 42 42 $10,248 $2,741 26.7%
90792 Psychiatric diagnostic evaluation with medical services Office 2021 15 18 $6,804 $2,180 32.0%
99497 Advance care planning by the physician or other qualified health care professional, first 30 minutes Office 2021 32 32 $5,344 $1,567 29.3%

About Dr. Rupal Shah, MD

Dr. Rupal Shah, MD is a Family Medicine healthcare provider based in Corona, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396730560.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rupal Shah, MD has received a total of $7,539 in payments from pharmaceutical and medical device companies, with $121.73 received in 2024. These payments were reported across 236 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,019).

As a Medicare-enrolled provider, Shah has provided services to 1,356 Medicare beneficiaries, totaling 2,404 services with total Medicare billing of $204,160. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Corona, CA
  • Active Since 09/14/2005
  • Last Updated 06/15/2012
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1396730560

Products in Payments

  • NURTEC ODT (Drug) $1,905
  • FARXIGA (Drug) $1,823
  • Aimovig (Biological) $751.86
  • Repatha (Biological) $442.00
  • Prolia (Biological) $209.84
  • Otezla (Drug) $155.11
  • EVENITY (Biological) $140.14
  • JARDIANCE (Drug) $137.50
  • UBRELVY (Drug) $126.12
  • Micra (Device) $124.20
  • Epclusa (Drug) $120.00
  • APTIOM (Drug) $102.86
  • Kerendia (Drug) $102.74
  • UPTRAVI (Drug) $98.80
  • INSPIRIS RESILIA aortic valve (Device) $95.89
  • XARELTO (Drug) $94.68
  • STIOLTO RESPIMAT (Drug) $93.66
  • SHINGRIX (Biological) $53.41
  • ImmunoCAP (Device) $46.78
  • SYMBICORT (Drug) $43.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Corona